To maximise DFID\u2019s resources for our COVID-19 response we are: using HMG\u2019s crisis reserve, adapting and scaling up existing programmes that respond to COVID-19, and reviewing programmes that can be slowed or paused to free up resources e.g. preparation for delayed international events or support for delayed elections. We will continue to closely monitor the scenarios and impacts of COVID-19 in vulnerable countries, to ensure the best possible use of 0.7 in our response to COVID-19 and HMG\u2019s wider development priorities.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"} } , "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"} , "answeringMemberPrinted" : {"_value" : "Wendy Morton"} , "dateOfAnswer" : {"_value" : "2020-05-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-05-12T16:15:27.413Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "20"} , "answeringDeptShortName" : {"_value" : "International Development"} , "answeringDeptSortName" : {"_value" : "International Development"} , "date" : {"_value" : "2020-05-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Development Aid: Coronavirus"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for International Development, pursuant to the Answer of 4 May 2020 to Question 40723 on Overseas Aid: Coronavirus, which of her Department's planned spend and objectives have been deprioritised in order to divert resources to the covid-19 response.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4603", "label" : {"_value" : "Biography information for Preet Kaur Gill"} } , "tablingMemberConstituency" : {"_value" : "Birmingham, Edgbaston"} , "tablingMemberPrinted" : [{"_value" : "Preet Kaur Gill"} ], "uin" : "43720"} , {"_about" : "http://data.parliament.uk/resources/1193072", "AnsweringBody" : [{"_value" : "Department for International Development"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1193072/answer", "answerText" : {"_value" : "
DFID along with the Foreign and Commonwealth Office is leading on the UK Government\u2019s international response to COVID-19. DFID is surging staff internally to support this effort as its priority.<\/p>
57 Full Time Equivalent (FTE) staff have been moved into a new central team coordinating the overall COVID-19 response and a further 4 FTE staff have been surged into this team from across government. Delivery of the response itself is spread across the Department, with many staff across our International, Economic Development, Policy, Science and Research and geographical/corporate Divisions focusing on the immediate COVID-19 response and longer-term recovery.<\/p>
DFID has loaned staff with specific skillsets to other government departments in support of their COVID-19 work. 9 FTE staff have been deployed to support other government departments at this time.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"} } , "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"} , "answeringMemberPrinted" : {"_value" : "Wendy Morton"} , "dateOfAnswer" : {"_value" : "2020-05-12", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-05-12T16:31:56.37Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "20"} , "answeringDeptShortName" : {"_value" : "International Development"} , "answeringDeptSortName" : {"_value" : "International Development"} , "date" : {"_value" : "2020-05-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Development Aid: Coronavirus"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for International Development, pursuant to the Answer of 4 May 2020 to Question 40723 on Overseas Aid: Coronavirus, how many FTE staff have been moved to work on (a) her Department's and (b) other Departments' covid-19 response.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4603", "label" : {"_value" : "Biography information for Preet Kaur Gill"} } , "tablingMemberConstituency" : {"_value" : "Birmingham, Edgbaston"} , "tablingMemberPrinted" : [{"_value" : "Preet Kaur Gill"} ], "uin" : "43721"} , {"_about" : "http://data.parliament.uk/resources/1193075", "AnsweringBody" : [{"_value" : "Department for International Development"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1193075/answer", "answerText" : {"_value" : "
There are seven joint private offices across DFID, FCO and Defra: four offices are in the FCO at King Charles St, two offices in DFID at 22 Whitehall, and one office at Defra at 2 Marsham Street. Additionally, there are shared office spaces in DFID and the FCO for Ministers and private offices to use when away from their home location.<\/p>
FCO \u2013 King Charles Street<\/strong><\/p><\/td> DFID \u2013 22 Whitehall<\/strong><\/p><\/td> DEFRA - 2 Marsham St<\/strong><\/p><\/td><\/tr> Rt Hon James Cleverly MP<\/p><\/td> Baroness Sugg CBE<\/p><\/td> Rt Hon Lord Zac Goldsmith<\/p><\/td><\/tr> Lord Ahmad of Wimbledon<\/p><\/td> James Duddridge MP<\/p><\/td> <\/p><\/td><\/tr> Wendy Morton MP<\/p><\/td> <\/p><\/td> <\/p><\/td><\/tr> Nigel Adams MP<\/p><\/td> <\/p><\/td> <\/p><\/td><\/tr><\/tbody><\/table> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"}
}
, "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"}
, "answeringMemberPrinted" : {"_value" : "Wendy Morton"}
, "dateOfAnswer" : {"_value" : "2020-05-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-05-12T16:54:57.25Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "20"}
, "answeringDeptShortName" : {"_value" : "International Development"}
, "answeringDeptSortName" : {"_value" : "International Development"}
, "date" : {"_value" : "2020-05-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Department for International Development: Ministers' Private Offices"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for International Development, pursuant to the Answer of 4 May 2020 to Question 41134 on Department for International Development: Ministers' Private Offices, which of her Department's Ministers have their private offices in the (a) Foreign and Commonwealth Office, (b) Department for International Development and (c) Department for Environment, Food and Rural Affairs.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4603", "label" : {"_value" : "Biography information for Preet Kaur Gill"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Edgbaston"}
, "tablingMemberPrinted" : [{"_value" : "Preet Kaur Gill"}
], "uin" : "43722"}
, {"_about" : "http://data.parliament.uk/resources/1193140", "AnsweringBody" : [{"_value" : "Department for International Development"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1193140/answer", "answerText" : {"_value" : " The UK is at the forefront of global efforts to ensure equitable access to potential COVID-19 vaccines, treatments and tests, and is already strategically funding key organisations at the centre of the global response. We have committed over £313 million of UK aid to the Coalition for Epidemic Preparedness Innovations, the Wellcome Therapeutics Accelerator and the Foundation for Innovative New Diagnostics. This funding is alongside our investment in GAVI, the Vaccine Alliance, worth an equivalent of £330 million a year for five years, which will support the development, manufacture and delivery of COVID-19 vaccines, treatments and tests for people around the world.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"}
}
, "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"}
, "answeringMemberPrinted" : {"_value" : "Wendy Morton"}
, "dateOfAnswer" : {"_value" : "2020-05-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-05-12T16:23:20.533Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "20"}
, "answeringDeptShortName" : {"_value" : "International Development"}
, "answeringDeptSortName" : {"_value" : "International Development"}
, "date" : {"_value" : "2020-05-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Developing Countries: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for International Development, if she will publish her Department's plan to ensure equitable access to vaccines and medical tools for people in the Global South.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4603", "label" : {"_value" : "Biography information for Preet Kaur Gill"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Edgbaston"}
, "tablingMemberPrinted" : [{"_value" : "Preet Kaur Gill"}
], "uin" : "43724"}
, {"_about" : "http://data.parliament.uk/resources/1193142", "AnsweringBody" : [{"_value" : "Department for International Development"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1193142/answer", "answerText" : {"_value" : " The UK has long supported affordable and equitable access to essential medicines and vaccines in the UK, and for people living in the Global South. We have committed £250 million of UK aid \u2013 the largest contribution of any country - to the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a portfolio of Covid-19 vaccines that, once available, will be available to all. CEPI works with a range of partners to support equitable access for products that it supports. The UK has further committed £40 million to the Wellcome Therapeutics Accelerator and £23 million to the Foundation for Innovative New Diagnostics (FIND), both of which are central to efforts to accelerate development and access to new treatments and tests.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"}
}
, "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"}
, "answeringMemberPrinted" : {"_value" : "Wendy Morton"}
, "dateOfAnswer" : {"_value" : "2020-05-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-05-12T16:24:10.43Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "20"}
, "answeringDeptShortName" : {"_value" : "International Development"}
, "answeringDeptSortName" : {"_value" : "International Development"}
, "date" : {"_value" : "2020-05-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Developing Countries: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for International Development, what steps the Government will take to ensure pharamceutical companies in receipt of public funds allow equitable access to covid-19 vaccines and medical tools for people living in the global south.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4603", "label" : {"_value" : "Biography information for Preet Kaur Gill"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Edgbaston"}
, "tablingMemberPrinted" : [{"_value" : "Preet Kaur Gill"}
], "uin" : "43725"}
, {"_about" : "http://data.parliament.uk/resources/1193145", "AnsweringBody" : [{"_value" : "Department for International Development"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1193145/answer", "answerText" : {"_value" : " The Secretary of State has had a range of discussions on this issue with G7 counterparts along with a range of global partners on access to Covid-19 vaccines, tests and treatments. We support global collaboration, joining efforts to ensure equitable access to potential COVID-19 vaccines, treatments and tests, including for the poorest countries.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"}
}
, "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"}
, "answeringMemberPrinted" : {"_value" : "Wendy Morton"}
, "dateOfAnswer" : {"_value" : "2020-05-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-05-12T16:33:00Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "20"}
, "answeringDeptShortName" : {"_value" : "International Development"}
, "answeringDeptSortName" : {"_value" : "International Development"}
, "date" : {"_value" : "2020-05-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Developing Countries: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for International Development, what representations she has made to her counterpart in the US Administration on ensuring equitable access for countries in the Global South to (a) a covid-19 vaccine and (b) medical equipment needed to treat covid-19.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4603", "label" : {"_value" : "Biography information for Preet Kaur Gill"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Edgbaston"}
, "tablingMemberPrinted" : [{"_value" : "Preet Kaur Gill"}
], "uin" : "43726"}
, {"_about" : "http://data.parliament.uk/resources/1193148", "AnsweringBody" : [{"_value" : "Department for International Development"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1193148/answer", "answerText" : {"_value" : " DFID routes ODA funding for research into the development of vaccines and other medical tools to tackle COVID-19 through Product Development Partnership and other multilateral not for profit organisations. Besides having the best scientific expertise in their respective field, these funding platforms also have the legal and administrative expertise to ensure that, once developed, products are affordable and accessible to provide low and middle-income countries with the tools they need to tackle this disease in their country.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4358", "label" : {"_value" : "Biography information for Wendy Morton"}
}
, "answeringMemberConstituency" : {"_value" : "Aldridge-Brownhills"}
, "answeringMemberPrinted" : {"_value" : "Wendy Morton"}
, "dateOfAnswer" : {"_value" : "2020-05-12", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-05-12T16:36:32.797Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "20"}
, "answeringDeptShortName" : {"_value" : "International Development"}
, "answeringDeptSortName" : {"_value" : "International Development"}
, "date" : {"_value" : "2020-05-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Development Aid: Coronavirus"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for International Development, whether she plans to place conditions on ODA funding to large pharmaceutical companies that are developing vaccines and medical tools for covid-19.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4603", "label" : {"_value" : "Biography information for Preet Kaur Gill"}
}
, "tablingMemberConstituency" : {"_value" : "Birmingham, Edgbaston"}
, "tablingMemberPrinted" : [{"_value" : "Preet Kaur Gill"}
], "uin" : "43727"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 7, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}
|